2024
Complex Congenital Heart Disease in the Adult
Goldstein S, Krasuski R. Complex Congenital Heart Disease in the Adult. Annual Review Of Medicine 2024, 75: 493-512. PMID: 38285514, DOI: 10.1146/annurev-med-050922-052324.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCongenital heart diseaseAdult congenital heart diseaseComplex congenital heart diseaseHeart diseaseSevere birth defectsStructural abnormalitiesBirth defectsComplex lesionsFrequent causeHigh riskImprove outcomesPediatric outcomesHeterogeneous groupPalliative interventionsCardiovascular systemDiseaseAdultsOutcomesComplications
2022
Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations
Denoble A, Goldstein S, Grotegut C, Federspiel J. Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations. American Journal Of Obstetrics And Gynecology 2022, 226: s77. DOI: 10.1016/j.ajog.2021.11.146.Peer-Reviewed Original Research
2021
734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy
DeNoble A, Federspiel J, Wein L, Goldstein S, Grotegut C. 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy. American Journal Of Obstetrics And Gynecology 2021, 224: s460-s461. DOI: 10.1016/j.ajog.2020.12.757.Peer-Reviewed Original Research
2019
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)
Goldstein S, Green J, Huber K, Wojdyla D, Lopes R, Alexander J, Vinereanu D, Wallentin L, Granger C, Al-Khatib S. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). The American Journal Of Cardiology 2019, 124: 1406-1412. PMID: 31474328, PMCID: PMC7194994, DOI: 10.1016/j.amjcard.2019.07.046.Peer-Reviewed Original ResearchConceptsThyroid disease historyThyroid diseaseAtrial fibrillationDisease historyThromboembolic eventsClinical outcomesOutcomes of atrial fibrillationHistory of thyroid diseaseBaseline characteristics of patientsCox modelBenefits of apixabanOther Thromboembolic EventsCharacteristics of patientsEffects of anticoagulantsAdjusted hazard ratiosBaseline characteristicsCompare outcomesHazard ratioThyroidApixabanPatientsRandomized treatmentWarfarinHypothyroidismDisease
2017
The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes
Goldstein S, Ward C, Al-Khatib S. The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes. Journal Of Innovations In Cardiac Rhythm Management 2017, 9: 2996-3005. PMID: 32494470, PMCID: PMC7252881, DOI: 10.19102/icrm.2018.090103.Peer-Reviewed Original ResearchCongenital heart diseaseInherited arrhythmia syndromesSudden cardiac deathArrhythmia syndromesCardiac deathIncreased risk of sudden cardiac deathPrevention of sudden cardiac deathRisk of sudden cardiac deathHeart diseaseImplantable cardioverter-defibrillator (ICDCardioverter-defibrillator (ICDRisk stratification methodsNon-randomized studiesImplantable cardioverter-defibrillatorRandomized clinical trialsCardioverter-defibrillatorClinical trialsIncreased riskPatientsSyndromeDiseaseImplantationStratification methodICDDeathCongenital and Acquired Valvular Heart Disease in Pregnancy
Goldstein S, Ward C. Congenital and Acquired Valvular Heart Disease in Pregnancy. Current Cardiology Reports 2017, 19: 96. PMID: 28840470, DOI: 10.1007/s11886-017-0910-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsValvular heart diseaseHeart diseaseRisk of pregnancy-related complicationsManagement of valvular heart diseaseWomen of childbearing agePregnancy-related complicationsAcquired valvular heart diseaseRheumatic heart diseaseValvular abnormalitiesCongenital abnormalitiesCase reportSymptomatic diseaseChildbearing ageRegurgitant lesionsHemodynamic effectsPatient populationPregnancyPercutaneous interventionStenotic lesionsRefractory symptomsHigh riskObservational studyReviewThe numberDiseaseAbnormalities